Appointment of Nominated Adviser and Joint Broker

21 March 2012

Phorm, Inc.

("Phorm" or "the Company")

Appointment of Nominated Adviser and Joint Broker

Phorm, Inc., (AIM: PHRX and PHRM), the internet personalisation technology company, is pleased to announce that it has appointed Liberum Capital Limited to act as its Nominated Adviser and Joint Broker with immediate effect. The Company retains Mirabaud Securities as Joint Broker alongside Liberum Capital.

- Ends -

For enquiries:

Phorm, Inc.

Mark Williams +44 (0)20 7297 2067

Liberum Capital Limited (NOMAD and Joint Broker)

Chris Bowman / Richard Bootle +44 (0)20 3100 2222

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

A Delaware, US incorporated company, Phorm was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

For more information, please visit: www.phorm.com